High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms
- PMID: 32805210
- DOI: 10.1016/j.cbi.2020.109199
High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms
Abstract
Obesity is characterized by the deposition of excessive body fat, and is caused by energy imbalance, especially when consuming fat-rich diets. High fat diet (HFD)-associated obesity is greatly common in patients with non-alcoholic fatty liver disease (NAFLD) that is emerging as one of the most universal causes of liver disease worldwide, especially in Western countries. In spite of its high prevalence, only a small proportion of affected individuals will become inflamed, followed by fibrosis and chronic liver diseases, and most patients only show simple steatosis. In this case, the full comprehension of the mechanisms underlying the progression of NAFLD is of extreme significance; in spite of progress in this field, awareness on the development of NAFLD is still incomplete. Traditionally, liver steatosis is commonly connected with HFD, obesity, and insulin resistance (IR). Recently, various possible mechanisms have been put forward for liver damage, including endoplasmic reticulum stress, perturbation of autophagy, mitochondrial dysfunction, hepatocellular apoptosis, gut microbiota imbalance, dysregulation of microRNAs, and genetic/epigenetic risk factors, as well as an increase in inflammatory responses, among many others. Collectively, these proposed mechanisms allow for a variety of hits acting together on subjects to mediated NAFLD and will offer a more accurate explanation for progression of NAFLD. Therefore, this review summarizes the present information concerning NAFLD after HFD exposure, as well as discusses possible mechanisms through which it may arise.
Keywords: Apoptosis; High fat diet; Inflammation; Liver; NAFLD; Oxidative stress.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25. Free Radic Biol Med. 2017. PMID: 27890642
-
Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.Mol Nutr Food Res. 2019 Apr;63(8):e1800930. doi: 10.1002/mnfr.201800930. Epub 2019 Feb 4. Mol Nutr Food Res. 2019. PMID: 30680920
-
Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3655-3667. doi: 10.1016/j.bbadis.2018.09.027. Epub 2018 Sep 24. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 30261289
-
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).Metabolism. 2016 Aug;65(8):1038-48. doi: 10.1016/j.metabol.2015.12.012. Epub 2016 Jan 4. Metabolism. 2016. PMID: 26823198 Review.
-
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:55-65. doi: 10.1016/j.mce.2015.02.018. Epub 2015 Feb 24. Mol Cell Endocrinol. 2015. PMID: 25724480 Review.
Cited by
-
Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway.World J Gastroenterol. 2024 Aug 14;30(30):3584-3608. doi: 10.3748/wjg.v30.i30.3584. World J Gastroenterol. 2024. PMID: 39193572 Free PMC article.
-
International diet quality index and revised diet quality index relationship with non-alcoholic fatty liver disease: a case-control study.BMC Gastroenterol. 2023 Dec 14;23(1):441. doi: 10.1186/s12876-023-03082-x. BMC Gastroenterol. 2023. PMID: 38097953 Free PMC article.
-
Cheong-sang-bang-pung-san alleviated hepatic lipid accumulation by regulating lipid metabolism in vitro and in vivo.Front Pharmacol. 2023 Sep 6;14:1223534. doi: 10.3389/fphar.2023.1223534. eCollection 2023. Front Pharmacol. 2023. PMID: 37745047 Free PMC article.
-
Bacteroides and NAFLD: pathophysiology and therapy.Front Microbiol. 2024 Mar 20;15:1288856. doi: 10.3389/fmicb.2024.1288856. eCollection 2024. Front Microbiol. 2024. PMID: 38572244 Free PMC article. Review.
-
Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation.Med Sci (Basel). 2025 Aug 12;13(3):125. doi: 10.3390/medsci13030125. Med Sci (Basel). 2025. PMID: 40843747 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical